Echo Pharmaceuticals Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

Echo Pharmaceuticals General Information

Description

Operator of a pharmaceutical company intended for therapeutic applications and drug development involving lipophilic active ingredients. The company specializes in the extraction, purification, and formulation of cannabinoid-based compounds under controlled laboratory conditions, offering reference standards and active pharmaceutical ingredients as well as conducting clinical development of oral formulations with improved bioavailability and shelf stability, enabling research institutions and pharmaceutical developers to access materials for analytical use, clinical trials, and drug development programs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Robert Boyleweg 4
  • 2333 CG Leiden
  • Netherlands
+31 071
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Robert Boyleweg 4
  • 2333 CG Leiden
  • Netherlands
+31 071

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Echo Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 31-Jan-2023 Completed Generating Revenue
1. Reverse Merger 17-Apr-2019 Cancelled Generating Revenue
To view Echo Pharmaceuticals’s complete valuation and funding history, request access »

Echo Pharmaceuticals Patents

Echo Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4591855-A1 Stable dronabinol compositions Inactive 23-Jan-2024
ES-2962832-T3 Treatment of aged or uv damaged skin Active 29-Jul-2019
CA-3149298-A1 Treatment of aging or uv-damaged skin Pending 29-Jul-2019
EP-4003282-A1 Treatment of aging or uv-damaged skin Active 29-Jul-2019
EP-4003282-B1 Treatment of aging or uv-damaged skin Active 29-Jul-2019 A61K8/347
To view Echo Pharmaceuticals’s complete patent history, request access »

Echo Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Echo Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mibiton Venture Capital Minority
To view Echo Pharmaceuticals’s complete investors history, request access »

Echo Pharmaceuticals FAQs

  • When was Echo Pharmaceuticals founded?

    Echo Pharmaceuticals was founded in 2006.

  • Where is Echo Pharmaceuticals headquartered?

    Echo Pharmaceuticals is headquartered in Leiden, Netherlands.

  • What is the size of Echo Pharmaceuticals?

    Echo Pharmaceuticals has 17 total employees.

  • What industry is Echo Pharmaceuticals in?

    Echo Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Echo Pharmaceuticals a private or public company?

    Echo Pharmaceuticals is a Private company.

  • What is Echo Pharmaceuticals’s current revenue?

    The current revenue for Echo Pharmaceuticals is .

  • Who are Echo Pharmaceuticals’s investors?

    Mibiton has invested in Echo Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process